Persistent URL of this record https://hdl.handle.net/1887/3764358
Documents
In Collections
This item can be found in the following collections:
From failure to meet the clinical endpoint to US Food and Drug Administration approval: 15th antisense oligonucleotide therapy approved Qalsody (tofersen) for treatment of SOD1 mutated amyotrophic lateral sclerosis
- All authors
- Roon-Mom, W. van; Ferguson, C.; Aartsma-Rus, A.
- Date
- 2023-08-01
- Journal
- Nucleic Acid Therapeutics
- Volume
- 33
- Issue
- 4
- Pages
- 234 - 237